8VC · 27 October 2026

The Two-Antibody Problem: Announcing the BigHat-Anthropic Partnership

8VC

Anthropic and BigHat Biosciences demonstrated an AI-assisted antibody optimization pilot where Claude worked with a researcher to improve antibodies across multiple properties—binding, stability, and aggregation—marking an early proof-point for AI-lab partnerships in drug discovery.

Read the full post ↗

Topics: Biotech & Life Sciences · AI (Horizontal)

SandHill indexes 800+ venture capital blogs and newsletters and sends the best of them every Sunday. Browse the sources · browse by topic · read the blog.